Biomedical Research | Novartis

Media Release
Sep 01, 2022
Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
Story
Nov 01, 2022
A scientist from the start – Q&A with NIBR President Fiona Marshall
Story
Nov 18, 2021
The art of drug design in a technological age
Story
Nov 12, 2021
Stopping this coronavirus – and the next one
Media Release
Oct 28, 2020
Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19
Media Release
May 03, 2021
Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
Story
Jun 08, 2016
The future of chronic myeloid leukemia is evolving
Story
Mar 22, 2017
Striving to vanquish leukemia
Story
Sep 28, 2017
Novartis and UC Berkeley take on “undruggable” proteins in new collaboration
Story
Jul 29, 2019
Q&A with new NIBR CIO Dimitris Agrafiotis
Story
Oct 27, 2013
Young talent & emerging technologies come together at BioCamp
Story
Mar 14, 2016
When tiny brains are best for brain research